ATE305305T1 - Verwendung einer kombination von nicotinsäuren oder deren derivaten und riboflavin zur herstellung eines arzneimittels zur behandlung von primären kopfschmerzen - Google Patents

Verwendung einer kombination von nicotinsäuren oder deren derivaten und riboflavin zur herstellung eines arzneimittels zur behandlung von primären kopfschmerzen

Info

Publication number
ATE305305T1
ATE305305T1 AT01954332T AT01954332T ATE305305T1 AT E305305 T1 ATE305305 T1 AT E305305T1 AT 01954332 T AT01954332 T AT 01954332T AT 01954332 T AT01954332 T AT 01954332T AT E305305 T1 ATE305305 T1 AT E305305T1
Authority
AT
Austria
Prior art keywords
treatment
migraine
riboflavin
combination
derivatives
Prior art date
Application number
AT01954332T
Other languages
English (en)
Inventor
Giampiero Valletta
Original Assignee
Giampiero Valletta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giampiero Valletta filed Critical Giampiero Valletta
Application granted granted Critical
Publication of ATE305305T1 publication Critical patent/ATE305305T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
AT01954332T 2000-08-07 2001-07-20 Verwendung einer kombination von nicotinsäuren oder deren derivaten und riboflavin zur herstellung eines arzneimittels zur behandlung von primären kopfschmerzen ATE305305T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000RM000448A IT1320776B1 (it) 2000-08-07 2000-08-07 Composizione farmaceutica a base di un'associazione vitaminica per laterapia delle cefalee primarie
PCT/IT2001/000388 WO2002011731A2 (en) 2000-08-07 2001-07-20 Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches

Publications (1)

Publication Number Publication Date
ATE305305T1 true ATE305305T1 (de) 2005-10-15

Family

ID=11454879

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01954332T ATE305305T1 (de) 2000-08-07 2001-07-20 Verwendung einer kombination von nicotinsäuren oder deren derivaten und riboflavin zur herstellung eines arzneimittels zur behandlung von primären kopfschmerzen

Country Status (13)

Country Link
US (1) US7456291B2 (de)
EP (1) EP1318815B1 (de)
JP (1) JP2004505919A (de)
KR (1) KR100816140B1 (de)
CN (1) CN100408038C (de)
AT (1) ATE305305T1 (de)
AU (2) AU2001276672B2 (de)
CA (1) CA2417758C (de)
DE (1) DE60113704T2 (de)
ES (1) ES2248362T3 (de)
IT (1) IT1320776B1 (de)
RU (1) RU2274448C2 (de)
WO (1) WO2002011731A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8940326B2 (en) 2007-03-19 2015-01-27 Vita Sciences Llc Transdermal patch and method for delivery of vitamin B12
JP2014503592A (ja) * 2011-01-26 2014-02-13 ニコ ワールドワイド，インコーポレイテッド 片頭痛の療法
JP7499027B2 (ja) * 2019-12-27 2024-06-13 小林製薬株式会社 内服用医薬組成物
CA3175608A1 (en) * 2020-04-22 2021-10-28 Linzy O. Scott, Iii Treatment of conditions associated with thyroid hormone

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2480517A (en) * 1946-03-02 1949-08-30 Merck & Co Inc Fused riboflavin-amide
DE1670342A1 (de) * 1966-04-23 1970-10-29 Albert Ag Chem Werke Verfahren zur Herstellung eines neuen nikotinsauren Salzes
SU1168262A1 (ru) * 1981-02-13 1985-07-23 Белорусский Научно-Исследовательский Институт Неврологии,Нейрохирургии И Физиотерапии Способ лечени мигрени
AU587863B2 (en) * 1985-10-07 1989-08-31 Basf Aktiengesellschaft Vitamin-containing granules and production thereof
US4973467A (en) * 1989-10-13 1990-11-27 Natrol, Inc. Dietary supplement for adults
US5246943A (en) * 1992-05-19 1993-09-21 Warner-Lambert Company Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
US5571441A (en) * 1994-11-01 1996-11-05 The Procter & Gamble Company Nutrient supplement compositions providing physiologic feedback
GB9601398D0 (en) * 1996-01-24 1996-03-27 Piper Edwina M Composition
US6017946A (en) * 1997-10-08 2000-01-25 Posner; Robert Serotonin containing formulation for oral administration and method of use
US6068999A (en) 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
IT1306141B1 (it) * 1999-05-17 2001-05-30 Giampiero Valletta Composizione per il trattamento del prurito uremico e di forme diprurito non riconducibili a lesioni organiche.
RU2149001C1 (ru) * 1999-09-09 2000-05-20 Открытое акционерное общество "Химикофармацевтический комбинат "Акрихин" Ноотропное лекарственное средство и способ его получения

Also Published As

Publication number Publication date
KR20030022352A (ko) 2003-03-15
KR100816140B1 (ko) 2008-03-21
CN100408038C (zh) 2008-08-06
IT1320776B1 (it) 2003-12-10
AU7667201A (en) 2002-02-18
US7456291B2 (en) 2008-11-25
RU2274448C2 (ru) 2006-04-20
DE60113704D1 (de) 2006-02-09
CN1635893A (zh) 2005-07-06
US20030181459A1 (en) 2003-09-25
ES2248362T3 (es) 2006-03-16
WO2002011731A2 (en) 2002-02-14
WO2002011731A3 (en) 2002-08-15
CA2417758C (en) 2009-09-08
CA2417758A1 (en) 2002-02-14
EP1318815B1 (de) 2005-09-28
ITRM20000448A1 (it) 2002-02-07
ITRM20000448A0 (it) 2000-08-07
AU2001276672B2 (en) 2006-06-01
JP2004505919A (ja) 2004-02-26
DE60113704T2 (de) 2006-07-06
EP1318815A2 (de) 2003-06-18

Similar Documents

Publication Publication Date Title
YU45403A (sh) Novi 1,2-difenil-azetidinoni, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena za lečenje poremećaja u metabolizmu lipida
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
TR200200068T2 (tr) Nematisital triflüorobütenler
MXPA03009840A (es) Derivados de fenilurea sustituidos con carboxamida y metodo para la produccion de los mismos como farmacos.
TNSN05194A1 (en) Substituted n-arylheterocycles, method for production and use thereof as medicaments
NO20050701L (no) 4-pyrrolidino-fenyl-benzyleter derivater
EA200300248A1 (ru) Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции
BR0313176A (pt) Composições de pirazol úteis como inibidores de gsk-3
MA27134A1 (fr) Derives diarylcycloalkyle, leur procede de preparation et leur utilisation en tant qu'activateurs des ppar
DK0725779T3 (da) Hidtil ukendte (R)-5-Carbamoyl-8-fluor-3-N,N-disubstitueret-amino-3,4-dihydro-2H-1-benzopyraner
NO20050514L (no) Sammensetning og antiviral aktivitet til substituerte azaindoloksoeddikpiperazinderivater
HUP0103063A2 (hu) Új 2H-piridazin-származékok, alkalmazásuk, ilyen hatóanyagot tartalmazó gyógyászati készítmények, és eljárás a hatóanyag előállítására
IL165217A0 (en) Pesticidal pyridinecarboxamide derivatives
DE69905878D1 (de) Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen
ATE553095T1 (de) Neue imidazolderivate, deren herstellung und deren verwendung als intermediate zur herstellung von arzneimitteln und pestiziden
FR2804286B1 (fr) Utilisation de derives de polyaminoacides comme agents conservateurs, compositions les comprenant et procede de conservation les utilisant
DE60108626D1 (de) Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b] pyridinen als cyclin-abhängige kinase-hemmer
IS6914A (is) 2-þíó-útskiptar imídasólafleiður og notkun þeirraí lyfjaiðnaðinum
ATE282615T1 (de) Neue beta-amyloid inhibitoren, verfahren zu deren herstellung und deren verwendung als arzneimittel
NO20040821L (no) 3-substituerte 6,7-dihydroksytetrahydroisokinolinderivater for andvendelse som antibakterielle midler.
BR0113461A (pt) Compostos ou sais farmaceuticamente aceitáveis, composições farmacêuticas, método de tratamento de doença ou condição mediada por erab, hadh2 ou (beta)-amilóide em mamìferos, métodos de inibição ou modulação da atividade enzimática de erab ou hadh2 e método de tratamento de mal de alzheimer ou demência em mamìferos
IL162314A (en) Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides, processes for their preparation, pharmaceutical compositions comprising them and uses thereof
ATE305305T1 (de) Verwendung einer kombination von nicotinsäuren oder deren derivaten und riboflavin zur herstellung eines arzneimittels zur behandlung von primären kopfschmerzen
PT1254905E (pt) 4-(2-piridil) piperizinas possuindo actividade agonista do receptor 5ht7
MY159418A (en) New derivatives of flavones, their preparation process, their use as medicaments, pharmaceutical compositions and new use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1318815

Country of ref document: EP